Who is sponsoring NCT05693350?

NCT05693350 is sponsored by Assiut University.

What drugs are being tested in NCT05693350?

Interventions in NCT05693350: DUS.

What condition does NCT05693350 study?

NCT05693350 studies Recurrent Varicose Vein of Lower Limb (Disorder).

Is NCT05693350 still recruiting?

NCT05693350 is currently status unknown. Last updated 23 January 2023.

Last reviewed 2023-01-23 · How we verify

NCT05693350

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Etiology Of Recurrent Varicose Veins After Stripping Or Ablation Of Superficial Venous System

Status unknown Last updated 23 January 2023

What this trial tests

trial testing DUS in Recurrent Varicose Vein of Lower Limb (Disorder) in 50 participants. Status unknown.

Timeline

1 March 2023

Primary endpoint
1 October 2024

1 January 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 March 2023
Primary completion	1 October 2024
Estimated completion	1 January 2025

Drugs / interventions tested

Conditions studied

Recurrent Varicose Vein of Lower Limb (Disorder) — all drugs for Recurrent Varicose Vein of Lower Limb (Disorder) →

Sponsor

Assiut University

Who can join

Adults 18 to 60, any sex, with Recurrent Varicose Vein of Lower Limb (Disorder). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Number of patients and causes and patterns of recurrent varicose veins in the lower limbs in patients with history of varicose veins stripping or ablation of the superficial venous system.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05693350 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 23 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05693350.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing